Britain will ship 700 kilograms of nuclear waste to the United States under a deal to be announced by Prime Minister David Cameron at a nuclear security summit in Washington on Thursday, a British government source said. In return for the shipment, the largest ever movement of highly enriched uranium, the United States will send Europe a different type of nuclear waste that can be used to produce medical isotopes for the treatment of some cancers. "The prime minister will be announcing a landmark deal that we have agreed with the US and with (European Atomic Energy Community) Euratom," the British government source said, on condition of anonymity.
Wednesday, March 30, 2016
Britain to ship record amount of nuclear waste to U.S. - govt source
VIDEO: Hopes for new child cancer test
Britain to ship record amount of nuclear waste to U.S. - govt source
Britain will ship 700 kilograms of nuclear waste to the United States under a deal to be announced by Prime Minister David Cameron at a nuclear security summit in Washington on Thursday, a British government source said. In return for the shipment, the largest ever movement of highly enriched uranium, the United States will send Europe a different type of nuclear waste that can be used to produce medical isotopes for the treatment of some cancers. "The prime minister will be announcing a landmark deal that we have agreed with the US and with (European Atomic Energy Community) Euratom," the British government source said, on condition of anonymity.
VIDEO: Hopes for new child cancer test
Friday, March 25, 2016
Portola's long-acting blood thinner misses main study goal
Monday, March 21, 2016
Healthy Planet Essential for Global Health
When it comes to human health, it is time to rethink the notion of a balanced diet. We use an area the size of South America to grow our crops and an area the size of Africa for our livestock. On this scale, it is no surprise food production is the single largest driver of environmental degradation and a major contributor to greenhouse gas...
Scalia death a blow to Obamacare contraception challengers
By Lawrence Hurley WASHINGTON (Reuters) - Christian groups asking the U.S. Supreme Court to exempt them from the requirement to provide insurance covering contraception under President Barack Obama's healthcare law face an uphill battle following Justice Antonin Scalia's death last month. The remaining eight justices will consider seven related cases on whether nonprofit groups that oppose the requirement on religious grounds can object under a U.S. law called the Religious Freedom Restoration Act to a compromise version of the requirement offered by the Obama administration. The court, divided 4-4 between liberal and conservative justices without the conservative Scalia, is set to hear the case on Wednesday.
Friday, March 18, 2016
Barriers to healthcare more common for lesbians, gays, bisexuals
Guinea govt says two people have died from Ebola
Two people from the same family have died from Ebola in Guinea, the government said Thursday, as the WHO declared a flare-up of the virus in neighbouring Sierra Leone over. The cases are the first in Guinea since the country was declared Ebola free at the end of last year, and the UN health agency warned that a recurrence of the tropical disease -- which has claimed 11,300 lives since December 2013 -- remained a possibility. WHO declared that flare-up officially over on Thursday after no new cases were seen for 42 days -- the length of two Ebola incubation cycles.
Friday, March 11, 2016
Medecins Sans Frontieres files to block Pfizer patent on pneumonia vaccine in India
The charity Medicins Sans Frontieres has formally opposed U.S. firm Pfizer Inc's application for an Indian patent on a highly effective pneumonia vaccine, saying it could deprive many developing nations of cheaper copies of the drug. Some of the world's poorest countries and medical charities such as Medecins Sans Frontieres (MSF) depend on India's robust pharmaceutical industry to make cheaper forms of drugs and vaccines developed by big Western pharmaceutical companies such as Pfizer. If India granted Pfizer a patent on its Prevnar 13 pneumonia vaccine, Indian firms would not be able to produce affordable versions of it for domestic use or exports, MSF said.